<DOC>
	<DOCNO>NCT02643329</DOCNO>
	<brief_summary>The purpose study compare bioavailability generic product gliclazide ( Product Name : BF-Gliclazide Tablet 80mg , Manufactured Bright Future Pharmaceuticals Factory O/B Bright Future Pharmaceutical Laboratories Limited ) reference product ( Product Name : Diamicron 80mg Tablet , Manufactured Les Laboratoires Servier Industrie , France ) administer healthy volunteer fast condition . The plasma pharmacokinetic data gliclazide obtain two formulation use access interchangeability product .</brief_summary>
	<brief_title>Clinical Bioequivalence Study Two Gliclazide 80mg Tablet Formulations</brief_title>
	<detailed_description>The study design single-dose , two-treatment , two-period , two-sequence crossover washout period one two week . During study session , healthy male subject administer single oral dose 80 mg gliclazide ( one BF-Gliclazide Tablet 80 mg one Diamicron 80 mg Tablet ) overnight fast approximately 10 hour . 20 % glucose give orally subject 2 h drug administration minimize risk hypoglycaemia . Venous blood sample collect pre-dose ( 0 h ) 72 hour post-dose . The plasma concentration gliclazide determine validated assay . The non-compartmental method use analyze plasma concentration-time data calculate main pharmacokinetic parameter Cmax , Tmax , AUC0-last , AUC0-inf T1/2 . ANOVA conduct logarithmically transform Cmax , AUC0-last AUC0-inf . The two one-sided test use calculate 90 % confidence interval mean difference AUC0-last , AUC0-inf Cmax , assess bioequivalence two product .</detailed_description>
	<mesh_term>Gliclazide</mesh_term>
	<criteria>Body Mass Index 18 27 Accessible vein blood sample High probability compliance completion study No significant abnormality general physical examination ECG record within normal limit Biochemical haematological parameter within normal limit Subjects must agree take effective contraceptive method prevent partner become pregnant time first dose study medication one week last dose administration History hepatic , renal , biliary , cardiovascular , gastrointestinal , haematological chronic acute disease within 3 month prior study Clinically relevant abnormality physical examination , ECG evaluation , urine test , blood chemistry haematological test Tabacco use form Regular consumer alcohol Blood donation within 4 week prior start study Use gliclazide within 4 week study Use antidiabetic medication within 4 week study Volunteer clinical drug study within 2 month prior study Hypersensitivity gliclazide drug class History drug abude form</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>July 2016</verification_date>
</DOC>